A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
Authors
Keywords
-
Journal
eLife
Volume 9, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2020-10-05
DOI
10.7554/elife.56749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma
- (2019) Shuo Qie et al. Nature Communications
- The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
- (2019) Xing Huang et al. Autophagy
- LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma
- (2019) Ana Galan-Cobo et al. CANCER RESEARCH
- In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
- (2019) Milica Momcilovic et al. NATURE
- A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
- (2019) Hee Chan Yoo et al. Cell Metabolism
- Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
- (2018) Elisabeth F. P. Peterse et al. BRITISH JOURNAL OF CANCER
- The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
- (2018) Milica Momcilovic et al. CANCER CELL
- Recent Development of Small Molecule Glutaminase Inhibitors
- (2018) Minsoo Song et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Metabolic vulnerability of cisplatin‐resistant cancers
- (2018) Florine Obrist et al. EMBO JOURNAL
- Glutathione metabolism in cancer progression and treatment resistance
- (2018) Ankita Bansal et al. JOURNAL OF CELL BIOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
- (2018) Michael L Schulte et al. NATURE MEDICINE
- Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
- (2018) Angelika Bröer et al. Frontiers in Pharmacology
- Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5
- (2018) Cuifeng Wang et al. BIOMATERIALS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SIRT 4 Depletion Promotes HCC Tumorigenesis through Regulating AMPK α/ mTOR Axis
- (2018) Yun‐shan Wang et al. HEPATOLOGY
- Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
- (2018) Binghua Li et al. EBioMedicine
- A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis
- (2017) William P Katt et al. Future Medicinal Chemistry
- Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1
- (2017) Haojie Jin et al. GASTROENTEROLOGY
- Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
- (2017) Arimichi Okazaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic Imaging of Glutamine in Cancer
- (2017) Lin Zhu et al. JOURNAL OF NUCLEAR MEDICINE
- Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
- (2017) Jessica B. Spinelli et al. SCIENCE
- Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer
- (2017) Kristin K. Brown et al. Cancer Discovery
- Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
- (2015) N. Jacque et al. BLOOD
- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
- (2015) Yan Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Determination of Phosphate-activated Glutaminase Activity and Its Kinetics in Mouse Tissues using Metabolic Mapping (Quantitative Enzyme Histochemistry)
- (2014) Dennis Botman et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Prognostic PET 18F-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
- (2012) V. S. Nair et al. CANCER RESEARCH
- Preparation and Characterization of L-[5-11C]-Glutamine for Metabolic Imaging of Tumors
- (2011) W. Qu et al. JOURNAL OF NUCLEAR MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started